Long-term comparisons of the durability of 6 months versus 12 months antiviral therapy for hepatitis B after chemotherapy cessation

• Main Authors: Shih-Yu Yang (Author), Tsung-Hui Hu (Author), Yeh-Pin Chou (Author), Yuan-Hung Kuo (Author), Ming-Chao Tsai (Author), Kuo-Chin Chang (Author), Yi-Hao Yen (Author), Po-Lin Tseng (Author)
• Format: Book
• Published: Elsevier, 2023-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Prophylaxis antiviral therapy is recommended for patients with hepatitis B receiving chemotherapy but the ideal treatment duration after chemotherapy cessation needs more evidence for clarification. Aims: This study aimed to compare the relapse rate of short finite intervals of 6 months...